The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
T1abN0M0 HER2+ invasive breast cancer recurrence: Population-based cohort of 17,000+ consecutive breast cancers 2000-2006 at Kaiser Permanente Northern California (KPNC).
L. Fehrenbacher
No relevant relationships to disclose
P. Shiraz
No relevant relationships to disclose
M. Sattavat
No relevant relationships to disclose
A. Capra
No relevant relationships to disclose
C. Quesenberry
No relevant relationships to disclose
R. Fulton
No relevant relationships to disclose
L. A. Habel
Research Funding - Genentech